• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

Vical, Inc.

NASDAQ:VICL

$2.85 -$0.06 (-2.06%)

REAL-TIME: Last trade at

Jump to this page for:

Related Resources

Charting Vical's Latest Earnings Release

2/9/2012 by DailyFinance

6 Key Drivers for Biotechnology's 2012 Outlook

1/25/2012 by Minyanville

Biopharmaceutical Co Vical Prices 13.3M Share Offering At 12% Discount

1/6/2012 by Smart Money

Ending HIV/AIDS: Hedge Funds Believe in These 5 Companies

12/5/2011 by DailyFinance

Whoa! My Stock Just Crushed the Market!

9/23/2011 by DailyFinance

Why Did My Stock Just Die?

9/23/2011 by DailyFinance

Is Dendreon the Perfect Stock?

8/8/2011 by DailyFinance

Vical's CEO Discusses Q2 2011 Results - Earnings Call Transcript

8/3/2011 by Seeking Alpha Transcripts

What the Avastin Vote Means

6/30/2011 by Minyanville

Exelixis, YM Biosciences Lead Losers at Cancer Meeting

6/10/2011 by Minyanville

Roche Bests Bristol-Myers with Melanoma Study

6/6/2011 by Minyanville

Bristol, Roche Pact Puts Spotlight on Skin Cancer

6/2/2011 by Minyanville

Vical, Exelixis Surge as Cancer Meeting Nears

5/17/2011 by Minyanville

Vical's CEO Discusses Q1 2011 Results - Earnings Call Transcript

5/5/2011 by Seeking Alpha

Vical's CEO Discusses Q1 2011 Results - Earnings Call Transcript

5/5/2011 by Seeking Alpha Transcripts

Breakouts: 6 Stocks Showing New Strength

5/2/2011 by Seeking Alpha

7 Dirt Cheap Biotech Stocks With Huge Upside

4/27/2011 by Seeking Alpha

Chinese CEOs: Cook Your Books at Your Own Peril

4/13/2011 by Seeking Alpha

Vical: A Biotech Flying Under the Radar

4/6/2011 by Seeking Alpha

Major FDA Approval Could Pave the Way for These 5 Biotechs

3/31/2011 by Seeking Alpha

Vical Is Deeply Undervalued: Technology and Pipeline Offer Upside Reward

3/29/2011 by Seeking Alpha

Ipilimumab Approval Highlights Active Immunotherapy Renaissance

3/27/2011 by Seeking Alpha

18 Stocks on the 52 Week Low List Ready to Pop?

2/12/2011 by Seeking Alpha

Vical CEO Discusses Q4 2010 Results - Earnings Call Transcript

2/10/2011 by Seeking Alpha Transcripts

Vical CEO Discusses Q4 2010 Results - Earnings Call Transcript

2/10/2011 by Seeking Alpha

Seven Stocks With CEO Buying in the Past Week

2/8/2011 by Seeking Alpha

Vical Analyst and Investor Day Transcript

11/10/2010 by Seeking Alpha Transcripts

Vical Analyst and Investor Day Transcript

11/10/2010 by Seeking Alpha

15 Biotech Stocks With the Lowest Put/Call Ratios

10/13/2010 by Seeking Alpha

Bottom Fishing: Any Value in September's Losers?

10/7/2010 by Seeking Alpha

Early Market-Movers: Origin Agritech Limited, Vivus

9/22/2010 by Fox Business

UPDATE: Sanofi-Aventis' Limb Ischemia Drug Trial Disappoints

9/22/2010 by Smart Money

Vical Incorporated. Q2 2010 Earnings Call Transcript

8/3/2010 by Seeking Alpha Transcripts

Vical Incorporated. Q2 2010 Earnings Call Transcript

8/3/2010 by Seeking Alpha

UPDATE 1-Vical cancer drug shows promise in mid-stage trial

5/12/2010 by Reuters

Dendreon Drug Approval Raises Hopes For Others, Industry

4/30/2010 by Smart Money

UPDATE 1-Vical says PAD drug gets nod for late stage trial

1/12/2010 by Reuters

UPDATE 1-Vical's late-stage cancer trial gets positive review

12/28/2009 by Reuters

REFILE-BRIEF-Vical's late-stage trial gets positive review

12/28/2009 by Reuters

UPDATE 1-Vical says gets US patent for herpes DNA vaccine

12/22/2009 by Reuters
See More Articles...